Tulips Medicaments Pvt Ltd
Pharmaceutical company manufacturing, importing, exporting, and distributing medicines, drugs, and cosmetics.
1983 | Mumbai, Maharashtra (India) | Active
Tulips Medicaments Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 42 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -14.21%
- Ebitda -10.09%
- Net Worth -15.82%
- Total Assets -2.06%
About Tulips Medicaments
Tulips Medicaments Pvt Ltd (TMPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 1983 and has a history of 42 years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Pallavi Lakdawala, Kirtikumar Lakdawala, and Krinita Motwani serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1983PTC029343
- Company No.
029343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 1983
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Tulips Medicaments?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pallavi Lakdawala  | Director | 27-Mar-2010 | Current |
| Kirtikumar Lakdawala | Director | 02-Aug-1997 | Current |
| Krinita Motwani | Director | 27-Mar-2010 | Current |
Financial Performance of Tulips Medicaments.
Tulips Medicaments Pvt Ltd, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 14.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tulips Medicaments?
In 2021, Tulips Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Market Resonance Private LimitedKrinita Motwani is a mutual person
- Snoval Pharmaceuticals Pvt Ltd
Pallavi Lakdawala and Kirtikumar Lakdawala are mutual person
- Ecokrin Hygiene Private Limited
Pallavi Lakdawala, Kirtikumar Lakdawala and 1 more are mutual person
- Skyline Holdings Pvt Ltd
Pallavi Lakdawala and Kirtikumar Lakdawala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tulips Medicaments?
Unlock and access historical data on people associated with Tulips Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tulips Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tulips Medicaments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Tulips Medicaments
Recent activity within the organization
- Annual General Meeting
Tulips Medicaments Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
30 Sep 2024
- Balance Sheet
Tulips Medicaments Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
31 Mar 2024
- Director Appointment
Pallavi Kirtikumar Lakdawala was appointed as a Director was appointed as a Director on 27 Mar 2010 & has been associated with this company since 14 years 11 months .
27 Mar 2010
- Director Appointment
Krinita Karan Motwani was appointed as a Director was appointed as a Director on 27 Mar 2010 & has been associated with this company since 14 years 11 months .
27 Mar 2010
- Director Appointment
Kirtikumar Manilal Lakdawala was appointed as a Director was appointed as a Director on 02 Aug 1997 & has been associated with this company since 27 years 6 months .
02 Aug 1997
- Company Incorporation
Tulips Medicaments Pvt Ltd was registered on 18 Feb 1983 with Roc Mumbai & aged 42 years 11 days as per MCA records.
18 Feb 1983
Frequently asked questions
What is the Incorporation or founding date of Tulips Medicaments Pvt Ltd?
Tulips Medicaments Pvt Ltd was incorporated on 18 Feb 1983.
What is authorized share capital and paid-up capital of Tulips Medicaments Pvt Ltd?
The authorized share capital of Tulips Medicaments Pvt Ltd is ₹ 0.50 M and paid-up capital is ₹ 0.20 M.
Who are the current board members & directors of Tulips Medicaments Pvt Ltd?
Currently 3 directors are associated with Tulips Medicaments Pvt Ltd.
- Pallavi Kirtikumar Lakdawala
- Kirtikumar Manilal Lakdawala
- Krinita Karan Motwani
What is the registered address of Tulips Medicaments Pvt Ltd?
As per Ministry of Corporate Affairs (Mca), the registered address of Tulips Medicaments Pvt Ltd is 77/4 Lakdi Bunderdarukhana Reay Road India, Mumbai, Maharashtra, 400010.
What is the corporate identification number (CIN) and company number of Tulips Medicaments Pvt Ltd?
The corporate identification number (CIN) of Tulips Medicaments Pvt Ltd is U24239MH1983PTC029343 and the company number is 029343 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Tulips Medicaments Pvt Ltd, and by what percentage?
The financial reports for the fiscal year 2021 indicates that The net worth of Tulips Medicaments Pvt Ltd has experienced an downturn of -15.82%.
When was the last Balance Sheet of Tulips Medicaments Pvt Ltd filed with the ROC?
The most recent Balance Sheet for Tulips Medicaments Pvt Ltd was filed with the ROC on 31 Mar 2024.
People also Viewed
- Jignesh LakdawalaDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Mumbai, Maharashtra, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India